TSTsuyoshi Sasada

Tsuyoshi Sasada

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tsuyoshi Sasada has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Airway mucus plugs and ventilatory support during exacerbations, with subsequent outcomes, in patients with chronic obstructive pulmonary disease or emphysema

    by Tsuyoshi Sasada, Naoya Tanabe, Masataka Hirai, Hiro Ikeda, Naoto Tanaka, Takayasu Sugiyama, Yuto Otsuka, Chigusa Shirakawa, Hiroshi Kobe, Ryosuke Hirabayashi, et al.

  • Development and Validation of Clinical Scoring System to Estimate Mucus Plug Presence in Asthma

    by Tsuyoshi Sasada, Naoya Tanabe, Kaoruko Shimizu, Satoshi Marumo, Masataka Hirai, Yusuke Hayashi, Hirokazu Kimura, Atsuyasu Sato, Satoshi Morita, Satoshi Konno, et al.


  • Association between initial treatment response and prognosis in acute exacerbations of idiopathic pulmonary fibrosis treated with steroid pulse therapy

    by Tsuyoshi Sasada, Chigusa Shirakawa, Kazuma Nagata, Katsuyuki Furuta, Ryosuke Hirabayashi, Yuki Sato, Atsushi Nakagawa, Keisuke Tomii, Ryo Tachikawa


  • Open Access

    Changes in virus-related exacerbations of chronic respiratory diseases before and after the relaxation of COVID-19 infection control measures: a single-centre retrospective study in Japan

    by Tsuyoshi Sasada, Ryota Kishi, Chigusa Shirakawa, Ryosuke Hirabayashi, Yuki Sato, Kazuma Nagata, Atsushi Nakagawa, Keisuke Tomii, Koichi Ariyoshi, Ryo Tachikawa

    Background: Infection prevention and control (IPC) measures during the coronavirus disease 2019 (COVID-19) pandemic have led to a reduction in respiratory viral infections. However, these infections showed a resurgence in the post-COVID-19 era. Respiratory viral infections often exacerbate respiratory diseases. Objectives: This study aimed to determine how the relaxation of IPC measures affects the incidence of virus-related acute exacerbations in various respiratory diseases. Design: A retrospective study conducted at a tertiary care facility. Methods: This study retrospectively assessed data from adult patients aged 18 years and older who visited the emergency department (ED) of a tertiary medical centre in Kobe, Japan, from 1 October 2020 to 12 March 2024. We identified patients who visited because of chronic obstructive pulmonary disease (COPD) exacerbation, asthma exacerbation or acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) and classified them into two groups based on the pre-relaxation and post-relaxation of IPC measures. The detection rates and respiratory viruses identified using multiplex polymerase chain reaction were compared between the groups. Results: The total number of ED visits was 84,183 involving 129 cases of COPD exacerbation, 156 cases of asthma exacerbation and 68 cases of AE-IPF. Virus-related COPD exacerbations were significantly more frequent after the relaxation of IPC measures than before (7.7% vs 52.5%, p < 0.001). Similarly, virus-related asthma exacerbations occurred significantly more frequently after relaxation than before (39.7% vs 66.7%, p = 0.009). In contrast, no significant difference in the virus-associated AE-IPF was observed before and after relaxation (2.5% vs 5.0%, p = 0.61). Conclusion: Relaxation of IPC measures may increase virus-related exacerbations in COPD and asthma.


  • Association between initial treatment response and prognosis in acute exacerbations of idiopathic pulmonary fibrosis treated with steroid pulse therapy

    by Tsuyoshi Sasada, Chigusa Shirakawa, Kazuma Nagata, Ryo Tachikawa, Keisuke Tomii

    Background: Steroid pulse therapy is recommended for acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF). While previous studies on AE-IPF have focused on steroid dosages, the treatment course remains unexplored. Our study aims to evaluate the relationship between treatment course and patient prognosis. Methods: We conducted a single-center, retrospective cohort study. Patients showing an increase in the ratio of percutaneous oxygen saturation to inspired oxygen fraction (SpO2/FiO2) following 3 days of steroid pulse therapy were categorized as the "responder group". Those with decreased or unchanged SpO2/FiO2 were labeled the "non-responder group". Our primary outcome was the mortality rate at day 28; secondary outcomes involved a comparative analysis of the SpO2/FiO2 transitions observed on days 1, 4, and 28. Results: The final analysis included 100 AE-IPF patients treated with steroid pulse therapy. The 28-day mortality rate was 14% (8/59) in the responder group and 43% (17/40) in the non-responder group. The Responder group exhibited a significantly lower mortality rate at 28 days. Cox proportional hazards model revealed that the non-responder group (HR: 0.22, CI: 0.10–0.52) and a lower SpO2/FiO2 ratio on day 1 (HR: 0.18, CI:0.06–0.53) were independent predictors of 28-day mortality. At the same time, age and KL-6 levels were not significant factors. Of the responder group, 7 out of 60 patients exhibited a decline in SpO2/FiO2 from day 3 to day 28. Conclusion: The initial response to steroid pulse therapy in AE-IPF patients may be associated with mortality at day 28.

  • Open Access

    Multiple pulmonary nodules with diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and minute pulmonary meningothelial‐like nodules

    by Tsuyoshi Sasada, Ryo Tachikawa, Shigeo Hara, Keisuke Tomii

    Key message: A 78‐year‐old woman presented with multiple pulmonary nodules, mixed with solid and ground‐glass nodules. We pathologically confirmed that the multiple pulmonary nodules were a combination of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) and multiple pulmonary meningothelial‐like nodules (MPMNs). This is the first case report of concurrent DIPNECH and MPMNs.

  • Open Access

    A rare case of tumor‐to‐tumor metastasis from thymic carcinoma to an ovarian mature teratoma

    by Tsuyoshi Sasada, Chigusa Shirakawa, Ryo Tachikawa, Daisuke Yamashita, Keisuke Tomii

    Metastasis from one neoplasm to another is referred to as tumor-to-tumor metastasis (TTM). TTM is rarely observed. Here, we present a patient with TTM from a thymic carcinoma to an ovarian mature teratoma. A 25-year-old woman, diagnosed with unresectable thymic carcinoma, presented with a cyst with a solid tumor component in her right ovary. Laparoscopic cystectomy of the right ovary revealed that the solid tumor was a distant metastasis of the thymic carcinoma in an ovarian mature teratoma. The possibility of malignant transformation of the ovarian mature teratoma was ruled out, enabling accurate staging of the thymic carcinoma. This case emphasizes the need for clinicians to consider TTM and the importance of pathological confirmation of TTM when investigating potential distant metastases.

  • Open Access

    Incidence and causative agent distribution of viral-induced paediatric asthma exacerbations under strict infection control measures: a single-centre retrospective study in Japan

    by Tsuyoshi Sasada, Ken Hayashi, Ikuo Okafuji, Chisato Miyakoshi, Satoru Tsuruta

    The prevalence of respiratory viruses in children changed under strict infection control measures during the coronavirus disease 2019 (COVID-19) outbreak. In this study, we investigated the frequency of viral detection in the nasopharynx of paediatric patients with asthma exacerbations requiring hospitalization during the COVID-19 pandemic, as well as the distribution of causative viruses. We included paediatric patients admitted for asthma exacerbations between November 2020 and December 2022 at a single centre in Kobe, Japan. Demographic, clinical, and laboratory data were collected from their medical records and using additional questionnaires. All patients enrolled in this study met the diagnostic criteria for asthma exacerbations outlined in the Japanese Pediatric Guideline for the Treatment and Management of Bronchial Asthma 2020. Statistical differences were calculated using univariate analyses (chi-square or Mann‒Whitney U test). We enrolled 203 children hospitalized for asthma attacks and collected nasopharyngeal samples from 189 patients. The median patient age was 3.0 years. Asthma severity was classified as mild (4.0%), moderate (82.3%), or severe (13.8%). The proportion of viral respiratory infections was 95.2% (180/189). The rate of patients with multiple viral infections was 20.6% (39/189). The most frequently detected pathogens were rhinovirus and enterovirus (RV/EV) at 69.3% (131/189), allowing for duplicate detection, followed by respiratory syncytial virus (RSV) at 28.6% (54/189). We also detected RV/EV almost every month compared to RSV and other viruses. In addition, RV/EV-positive patients were significantly older (p = 0.033), exhibited higher WBC counts (p < 0.001) and higher Eos counts (p < 0.001), had elevated total IgE levels (p < 0.001) and house dust mite-specific IgE levels (p = 0.019), had a shorter duration of hospitalization (p < 0.001), and had a shorter duration of oxygen therapy (p < 0.001). In patients positive for RV/EV, the use of ICSs significantly reduced the severity of the condition (p < 0.001). Even under strict infection control measures, respiratory viruses were detected in the nasopharynx of almost all paediatric patients who had asthma exacerbations requiring hospitalization.